Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003
Ezetimibe added to statin therapy after acute coronary syndromes
Christopher P. Cannon Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J. Wouter Jukema; Gaetano M. De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musline; Eugene Braunwald; Robert M Califf; José Antonio Marin Neto; André Schmidt; IMPROVE-IT Investigators
The New England Journal of Medicine Waltham v. 372, n. 25, p. 2387-2397, 2015
Waltham 2015
Disponible en
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2762049 Estantes Deslizantes )(Obténgalo)
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Camille A. Pearle James E Udelson; Mariusz Kruk; Harmony R Reynolds; Witold Ruzyllo; Zygmund Sadowski; Anna Teresinska; Barbosz Bychowiec; Thomas Höchtl; José Antonio Marin Neto; Eric A Cohen; Benita Busz Papiez; Paulo Caramori; Gervasio A Adilbrecht; Carey Kimmelstiel; Christopher E Buller; Sandra Forman; Gervasio A Lamas; Judith S Hochman; Annual Scientific Session (56. 2007 New York)
Journal of American College Cardiology New York v. 49, n. 9, on-line, 2007
New York 2007
Disponible en
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 1647082 ) y otras localizaciones(Obténgalo)
The occluded artery trial (OAT) viability ancillary study (OAT-NUC) influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone
James E. Udelson Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; José Antonio Marin Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman
American Heart Journal Philadelphia v. 161, n. 3, p. 611-621, 2011
Philadelphia 2011
Disponible en
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2282312 Estantes Deslizantes )(Obténgalo)
The occluded artery trial(OAT)viability ancillary study(OAT-NUC) influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone
James E. Udelson Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Anna Teresinska; Bartosz Bychowiec; José Antônio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt Sadowski; Witold Ruzyllo; Sandy A Forman; Debora J Kinan; Gervasio A Lamas; Judith S Hochman; Scientific Sessions of The American Heart Association(AHA) (2007 Orlando)
Abstracts Orlando, 2007
Orlando 2007
Disponible en
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 1642665 ) y otras localizaciones(Obténgalo)
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger
American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005
Orlando 2005
Disponible en
FM - Fac. Medicina
(FM BCBIB )(Obténgalo)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger
American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005
Orlando 2005
Disponible en
FM - Fac. Medicina
(FM BCBIB )(Obténgalo)
Página de Inicio
RSS
Feed
Pol��ticas
Hable con Nosotros
Logos de Redes Sociales: 